Goodrich Katherine
SEC CIK 2044770 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | Dir | 2,233 | — | $183.4K | 3 | 2025-12-15 | 2026-06-15 |
Most active insiders at TARS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.18M |
| 2 | LINK WILLIAM J PHD | Dir | — | $4.48M |
| 3 | Whitfield Dianne C. | CHRO | — | $2.69M |
| 4 | Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| 5 | Neervannan Seshadri | COO | — | $2.00M |
| 6 | Farrow Jeffrey S | See Remarks | — | $1.32M |
| 7 | Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| 8 | Wahl Bryan | GC | — | $850.4K |
| 9 | Goodrich Katherine | Dir | — | $183.4K |
| 10 | Goldberg Andrew D. | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-17 16:17 | 2026-06-15 | TARS | Tarsus Pharmaceuticals, Inc. | Goodrich Katherine | Dir | S - Sale | $62.08 | -2,954 | 2,233 | -57% | -$183.4K |
| D | 2026-06-16 16:05 | 2026-06-12 | TARS | Tarsus Pharmaceuticals, Inc. | Goodrich Katherine | Dir | M - OptEx | — | +2,954 | 5,187 | +132% | — |
| D | 2026-01-14 | 2025-12-15 | TARS | Tarsus Pharmaceuticals, Inc. | Goodrich Katherine | Dir | M - OptEx | — | +2,233 | 2,233 | New | — |
Purchase Sale Sale after option exercise All abbreviations